Yue Sun

No. 12 Wulumuqi Middle Road
Jing'an, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia.

Prognostic Value of Dynamic Measurable Residual Disease Monitoring by Multiflowcytometry in Elderly Patients With Nonintensively Treated Acute Myeloid Leukemia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: December 05, 2024

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation.

Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation.

Journal: Hematology (Amsterdam, Netherlands)

Published: September 27, 2024

STING mediates increased self-renewal and lineage skewing in DNMT3A-mutated hematopoietic stem/progenitor cells.

STING mediates increased self-renewal and lineage skewing in DNMT3A-mutated hematopoietic stem/progenitor cells.

Journal: Leukemia

Published: September 09, 2024

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells.

STING is crucial for the survival of RUNX1::RUNX1T1 leukemia cells.

Journal: Leukemia

Published: April 09, 2024

Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC-MRD and treatment guidance for elderly patients.

Minimal residual disease monitoring in acute myeloid leukemia: Focus on MFC-MRD and treatment guidance for elderly patients.

Journal: European journal of haematology

Published: November 24, 2023

STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.

STING activation in TET2-mutated hematopoietic stem/progenitor cells contributes to the increased self-renewal and neoplastic transformation.

Journal: Leukemia

Published: June 01, 2023

Catalytic Asymmetric Synthesis of Tröger's Base Analogues with Nitrogen Stereocenter.

Catalytic Asymmetric Synthesis of Tröger's Base Analogues with Nitrogen Stereocenter.

Journal: ACS central science

Published: September 22, 2022

Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease.

Correction to: A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease.

Journal: Annals of nuclear medicine

Published: January 12, 2020

Phase I clinical study with different doses of 99mTc-TRODAT-1 in healthy adults.

Phase I clinical study with different doses of 99mTc-TRODAT-1 in healthy adults.

Journal: Annals of nuclear medicine

Published: November 01, 2019

A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease.

A phase 2, open-label, multi-center study to evaluate the efficacy and safety of 99mTc-TRODAT-1 SPECT to detect Parkinson's disease.

Journal: Annals of nuclear medicine

Published: July 02, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026